Net Income

OnePlan's new release integrates Microsoft Copilot for AI-driven planning, adds language support, and enhances governance for global enterprises.

As AI reshapes financial communications, 5W PR launches a new division to help investment firms build trust and cut through the digital noise.

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

As Valentine's and Family Day approach, MADD Canada's new campaign confronts a rise in risky behaviour and a decline in public concern over impaired driving.

A new abrasive-free technology from ChEmpower promises to eliminate critical defects, boosting yield and performance for next-generation AI and HBM chips.

The AI-driven lender secured major Wall Street backing for its auto loans, signaling strong investor faith in its tech amid a shaky consumer credit market.

After a decade-long battle with Stage 4 cancer, one patient's cure spotlights a revolutionary immunotherapy and its potential to change cancer treatment.

A shipping firm's subsidiary is using complex crypto strategies to fund an ambitious AI roadmap, signaling a new era for corporate treasury management.

A new poll reveals a surge in AI-assisted resume lies, forcing Canadian employers to fight a high-tech war for talent and truth in the workplace.

New platform on AWS offers preemptive zero-trust security, making critical infrastructure invisible to attackers before they can even strike.

After years of frenzy, rising inventory and longer selling times are creating new opportunities for homebuyers in Northern Virginia's shifting market.

With its Phase 1 trial fully enrolled, Senti Bio’s logic-gated CAR-NK therapy shows deep, durable remissions, charting an expedited path for R/R AML.

Backed by Bessemer & GV, the startup led by Twilio's ex-CEO will commercialize the only fusion approach with proven net energy gain.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

Basketball icons partner with the Prostate Cancer Foundation in a new push for early screening, aiming to save lives and combat racial health disparities.

Radiation tech giant Mirion appoints three new executives, signaling a major strategic push into next-gen nuclear, advanced cancer care, and AI.

Amid a national organ shortage, a Virginia organization's use of new tech and community campaigns led to a 27.5% jump in organs transplanted since 2021.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.